Celdara Medical, LLC announced today that it has received national recognition from the Small Business Administration (SBA) in the form of a Tibbetts Award. The award recognizes unique contributions to the Small Business Innovation Research (SBIR) Program. John Williams, the Director of Innovation and Technology in the Office of Investment and Innovation at the SBA commented, “[Celdara Medical’s] outstanding work has contributed greatly to the success of the SBIR program.”
The SBIR program encourages businesses to engage in innovative research and development (R&D) projects that have exceptional potential for commercialization. At NIH, this means the development of therapies and diagnostics that improve human health. Administered through a competitive peer review process, SBIR enables small businesses to achieve their goals through grants and contracts for R&D. By accelerating entrepreneurial businesses and aligning them with the nation's R&D efforts, high-tech innovation is stimulated and the United States gains economic benefits while meeting its research and development needs. SBIR was established in 1982 by legislation from New Hampshire Senator Warren Rudman.
Named after Roland Tibbetts, the universally acknowledged father of the SBIR program and a New Hampshire native son, the Tibbetts Award recognizes those individuals and firms that have made a substantial technological and socio-economic impact and exemplify the very best in SBIR achievement. Award winners are selected based on the economic impact of their technological innovation, and the extent to which that innovation served national R&D needs, encouraged diverse participation, and increased the commercialization of the nation’s investments in research.
“For the high-risk, high-reward R&D in which Celdara Medical specializes, SBIR is essential. To be recognized for our work with the SBIR program is an honor, and all the more so as the award is named for Mr. Tibbetts, the originator of one of the most successful initiatives – whether measured in terms of technological or economic development – that this or any government has undertaken”, said Jake Reder, Ph.D., cofounder and CEO of Celdara Medical. “This prestigious award is a testament to the creativity, dedication, and passion of our employees, the many NIH staff that have supported us over the years, and our outstanding scientific collaborators at leading universities across the country. We are immensely thankful for them, for this recognition, and for the opportunity to play a role in this great work.”
Dr. Michael Fanger, Cofounder, Chairman, and CSO added, “SBIR support has been a critically important part of our business and our success over the years. The impact of the program on us and on the country as a whole is both unique and compelling. Our representatives on both sides of the aisle have long recognized this. We’re heartened to see the current congressional expansion of the program, and are fully confident that additional expansion will continue to yield outsized returns. We look forward to supporting the SBIR program in every way we can long into the future.”
About Celdara Medical, LLC
Celdara Medical was founded by Drs. Jake Reder and Michael Fanger in 2008, and is headquartered at the Dartmouth Regional Technology Center (DRTC) in Lebanon, NH. Celdara Medical builds academic and early-stage innovations into high-potential medical companies, identifying discoveries of exceptional value at the earliest stages and moving them toward the market. Celdara Medical partners with inventors and their institutions, providing the developmental, financial, and business acumen required to bridge discovery and profitability. With robust funding options, a diverse and high impact Programmatic pipeline, and partnerships with world-class academic institutions and industry leaders, Celdara Medical navigates all aspects of a complex industry, accelerating science to improve human health.